Clinical Trial Detail

NCT ID NCT03387020
Title Ribociclib and Everolimus in Treating Children With Recurrent or Refractory Malignant Brain Tumors
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements no
Sponsors Pediatric Brain Tumor Consortium
Indications

central nervous system embryonal carcinoma

malignant glioma

brain stem cancer

brain stem glioma

medulloblastoma

atypical teratoid rhabdoid tumor

malignant ependymoma

Therapies

Ribociclib

Ribociclib + Everolimus

Age Groups: child adult

No variant requirements are available.